The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Lupus - Lupus syndrome (see also Vd)
Publications
Do selected drugs increase the risk of lupus? A matched case-control study.
British journal of clinical pharmacology 2010 Oct;70;588-96 — 2010 Oct — 588-96
[Carbamazepine-induced systemic lupus erythematosus--a case report].
Neurologia i neurochirurgia polska 2006 Mar-Apr;40;151-5 — 2006 Mar-Apr — 151-5
[Chest pain, reduced physical activity, and polyserositis in a 35-year old patient with anticonvulsive medication].
Der Internist 2006 Jan;47;69-75 — 2006 Jan — 69-75
Lupus and pulmonary nodules consistent with bronchiolitis obliterans organizing pneumonia induced by carbamazepine.
Mayo Clinic proceedings 1997 Dec;72;1145-7 — 1997 Dec — 1145-7
A case of drug induced lupus due to carbamazepine.
The Journal of rheumatology 1987 Jun;14;599-600 — 1987 Jun — 599-600